Bahrain authorizes AstraZeneca's anti-COVID drug for emergency use

Middle East
14-11-2021 | 14:47
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
Bahrain authorizes AstraZeneca's anti-COVID drug for emergency use
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
0min
Bahrain authorizes AstraZeneca's anti-COVID drug for emergency use
Bahrain has approved the emergency use of AstraZeneca's anti-COVID drug Evusheld, the state news agency reported on Sunday.

Bahrain has become the first country to authorize the drug, which will be limited to adults who suffer from immunodeficiency or who are taking immunosuppressants, as well as individuals with occupations that put them at risk of transmission, the news agency said.
 
 
 
REUTERS

Breaking Headlines

Bahrain

AstraZeneca

Covid-19

Coonavirus

Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More